Back to Search
GLENN LIU, MD
MD
Medical Oncology Physician
NPI: 1629039078IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
40193(WI)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
JEFFERSON MEDICAL COLLEGE OF THOMAS JEFFERSON UNIVERSITY
Class of 1997
Research & Publications (20)
An open-label, multicenter, phase I/II study of single-agent AT-101 in men with castrate-resistant prostate cancer.
PMID 19366825·Clin Cancer Res·2009
3-trial
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide g3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors.
PMID 18451239·Clin Cancer Res·2008
3-trial
Two-faced reactivity of alkenes: cis- versus trans-aminopalladation in aerobic Pd-catalyzed intramolecular aza-Wacker reactions.
PMID 17439217·J Am Chem Soc·2007
8-other
Highly regioselective Pd-catalyzed intermolecular aminoacetoxylation of alkenes and evidence for cis-aminopalladation and S(N)2 C-O bond formation.
PMID 16734468·J Am Chem Soc·2006
8-other
Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study.
PMID 16027440·J Clin Oncol·2005
3-trial
A Phase II trial of flavopiridol (NSC #649890) in patients with previously untreated metastatic androgen-independent prostate cancer.
PMID 14871968·Clin Cancer Res·2004
3-trial
Phase II study of 1alpha-hydroxyvitamin D(2) in the treatment of advanced androgen-independent prostate cancer.
PMID 14519629·Clin Cancer Res·2003
3-trial
Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer.
PMID 14578686·Invest New Drugs·2003
3-trial
Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
PMID 12231522·Clin Cancer Res·2002
3-trial
Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy.
PMID 11895899·Clin Cancer Res·2002
3-trial
In vivo selection of kinase-responsive RNA elements controlling alternative splicing.
PMID 19386606·J Biol Chem·2009
8-other
OCPAT: an online codon-preserved alignment tool for evolutionary genomic analysis of protein coding sequences.
PMID 17877817·Source Code Biol Med·2007
8-other
[The character of heredity and biological function of insulin-like growth factor 2].
PMID 16118146·Yi Chuan·2002
8-other
Transcription of essential cell division genes is linked to chromosome replication in Escherichia coli.
PMID 11401698·Mol Microbiol·2001
8-other
Destruction of SO2 on Au and Cu nanoparticles dispersed on MgO(100) and CeO2(111).
PMID 19634883·J Phys Chem A·2010
8-other
Differential diagnosis between benign and malignant gallbladder diseases with real-time contrast-enhanced ultrasound.
PMID 19657645·Eur Radiol·2010
8-other
Vitamin D mediates its action in human colon carcinoma cells in a calcium-sensing receptor-dependent manner: downregulates malignant cell behavior and the expression of thymidylate synthase and survivin and promotes cellular sensitivity to 5-FU.
PMID 19621386·Int J Cancer·2010
8-other
Interleukin10 -592 promoter polymorphism associated with gastric cancer among Asians: a meta-analysis of epidemiologic studies.
PMID 19669876·Dig Dis Sci·2010
1-meta
Simultaneous detection of dopamine, ascorbic acid, and uric acid at electrochemically pretreated carbon nanotube biosensors.
PMID 19616125·Nanomedicine·2010
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 265-1700
Quick Facts
- NPI
- 1629039078
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 29
- Publications
- 20
Are you this provider?
Claim Your Profile